title: A novel SCN9A mutation responsible for primary erythromelalgia and is resistant to the treatment of sodium channel blockers.
abstract: Primary erythromelalgia (PE) is an autosomal dominant neurological disorder characterized by severe burning pain and erythema in the extremities upon heat stimuli or exercise. Mutations in human SCN9A gene, encoding the α-subunit of the voltage-gated sodium channel, Na(v)1.7, were found to be responsible for PE. Three missense mutations of SCN9A gene have recently been identified in Taiwanese patients including a familial (I136V) and two sporadic mutations (I848T, V1316A). V1316A is a novel mutation and has not been characterized yet. Topologically, I136V is located in DI/S1 segment and both I848T and V1316A are located in S4-S5 linker region of DII and DIII domains, respectively. To characterize the elelctrophysiological manifestations, the channel conductance with whole-cell patch clamp was recorded on the over-expressed Chinese hamster overy cells. As compared with wild type, the mutant channels showed a significant hyperpolarizing shift in voltage dependent activation and a depolarizing shift in steady-state fast inactivation. The recovery time from channel inactivation is faster in the mutant than in the wild type channels. Since warmth can trigger and exacerbate symptoms, we then examine the influence of tempearture on the sodium channel conduction. At 35°C, I136V and V1316A mutant channels exhibit a further hyperpolarizing shift at activation as compared with wild type channel, even though wild type channel also produced a significant hyperpolarizing shift compared to that of 25°C. High temperature caused a significant depolarizing shift in steady-state fast inactivation in all three mutant channels. These findings may confer to the hyperexcitability of sensory neurons, especially at high temperature. In order to identifying an effective treatment, we tested the IC₅₀ values of selective sodium channel blockers, lidocaine and mexiletine. The IC₅₀ for mexiletine is lower for I848T mutant channel as compared to that of the wild type and other two mutants which is comparable to the clinical observations.
authors: Graduate Institute of Zoology, College of Life Sciences, National Taiwan University, Taipei, Taiwan.
authors: Min-Tzu
authors: MT
authors: Wu
authors: Po-Yuan
authors: PY
authors: Huang
authors: Chen-Tung
authors: CT
authors: Yen
authors: Chih-Cheng
authors: CC
authors: Chen
authors: Ming-Jen
authors: MJ
authors: Lee
mesh_terms: D000293:Adolescent; D000328:Adult; D000818:Animals; D001483:Base Sequence; D016466:CHO Cells; D006224:Cricetinae; D003412:Cricetulus; D004351:Drug Resistance / Q000502:physiology*; D004916:Erythromelalgia / Q000188:drug therapy* / Q000235:genetics* / Q000473:pathology; D005260:Female; D005799:Genes, Dominant / Q000235:genetics; D006801:Humans; D020128:Inhibitory Concentration 50; D008969:Molecular Sequence Data; D020125:Mutation, Missense / Q000235:genetics; D062556:NAV1.7 Voltage-Gated Sodium Channel / Q000235:genetics*; D018408:Patch-Clamp Techniques; D017422:Sequence Analysis, DNA; D026941:Sodium Channel Blockers / Q000494:pharmacology*; D013624:Taiwan; D013696:Temperature; D014162:Transfection
chemical_list: D062556:NAV1.7 Voltage-Gated Sodium Channel; C486866:SCN9A protein, human; D026941:Sodium Channel Blockers
references: J Biol Chem. 2006 Nov 24;281(47):36029-35
references: 17008310
references: Exp Neurol. 2009 Apr;216(2):383-9
references: 19162012
references: Brain. 2011 Jul;134(Pt 7):1972-86
references: 21705421
references: Ann Neurol. 2012 Jan;71(1):26-39
references: 21698661
references: J Physiol. 2010 Jun 1;588(Pt 11):1915-27
references: 20123784
references: Mol Pain. 2008 Jan 02;4:1
references: 18171466
references: J Neurol Neurosurg Psychiatry. 2006 Nov;77(11):1294-5
references: 17043302
references: Mol Pain. 2010 Apr 29;6:24
references: 20429905
references: J Neurosci. 1998 Dec 1;18(23):9607-19
references: 9822722
references: Angiology. 1994 Jun;45(6):451-3
references: 8203771
references: Ann Neurol. 2009 Jun;65(6):733-41
references: 19557861
references: Biochem Biophys Res Commun. 2009 Dec 11;390(2):319-24
references: 19800314
references: Trends Mol Med. 2005 Dec;11(12):555-62
references: 16278094
references: J Med Genet. 2004 Mar;41(3):171-4
references: 14985375
references: Brain. 2009 Jul;132(Pt 7):1711-22
references: 19369487
references: Proc Natl Acad Sci U S A. 2012 Jan 10;109(2):E93-102
references: 22160714
references: Hum Mutat. 2010 Sep;31(9):E1670-86
references: 20635406
references: Eur J Pain. 2010 Oct;14(9):944-50
references: 20385509
references: J Neurosci. 2004 Sep 22;24(38):8232-6
references: 15385606
references: Neurology. 2006 Nov 14;67(9):1563-7
references: 16988069
references: Am J Hum Genet. 2001 May;68(5):1277-82
references: 11283792
references: Nat Rev Neurol. 2011 Jan;7(1):51-5
references: 21079636
references: J Invest Dermatol. 2005 Jun;124(6):1333-8
references: 15955112
references: Clin Exp Dermatol. 2009 Dec;34(8):e640-2
references: 19549232
references: Nat Commun. 2012 Apr 24;3:791
references: 22531176
references: J Clin Invest. 2007 Dec;117(12):3603-9
references: 18060017
references: J Physiol. 2003 Jan 15;546(Pt 2):565-76
references: 12527742
references: Mol Pain. 2007 Jan 19;3:3
references: 17239250
references: Semin Cell Dev Biol. 2006 Oct;17(5):571-81
references: 17123847
references: Circulation. 1964 Jan;29:136-41
references: 14105024
references: Arch Dermatol. 2000 Mar;136(3):330-6
references: 10724194
references: Neuroscience. 2008 Jan 24;151(2):544-57
references: 18082972
references: Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1527-32
references: 9037087
references: Clin Orthop Relat Res. 1979 Oct;(144):249-54
references: 535232
references: J Neurol. 2007 Feb;254(2):210-4
references: 17294067
references: J Neurosci. 2006 Nov 29;26(48):12566-75
references: 17135418